Matthew C. Somerville

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Effect of Dutasteride on the Risk of Prostate Cancer

Gerald L. Andriole, David G. Bostwick, Otis W. Brawley et al. · New England Journal of Medicine · 2010 · 1.1K citations · Full text

Medicine, Pharmacology, Urology +12

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial

J. Curtis Nickel, Claus G. Roehrborn, Michael P. O’Leary et al. · European Urology · 2007 · 419 citations · Full text

Medicine, Surgery, Urology +17

CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

Gerald L. Andriole, David G. Bostwick, Otis W. Brawley et al. · The Journal of Urology · 2004 · 290 citations

Medicine, Pharmacology, Urology +12

Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention Trial

J. Curtis Nickel, Claus G. Roehrborn, Michael P. O’Leary et al. · The Journal of Urology · 2007 · 102 citations

Medicine, Pathology, Urology +9